LIFEMD, INC. (LFMD) Free cash flow
- Free cash flow · 12 months (USD): Value $-11.06M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value -5.77%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $-11.06M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $-9.91M − $1.15M ≈ $-11.06M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | -5.77% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $-11.06M ÷ $191.59M × 100 ≈ -5.77% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $-9.91M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 0.39× | Operating cash flow / net income. Period ending 2026-06-30. $-9.91M ÷ $-25.40M ≈ 0.39× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | -9.91M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations |
| Capital spending | 1.15M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | -11.06M USD | Net Cash Provided by (Used in) Operating Activities · Net Cash Provided by (Used in) Operating Activities, Continuing Operations · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 191.59M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | -25.40M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $-11.06M | (m) | $-9.91M | $1.15M | (m) | $191.59M | (m) | $-25.40M | (m) | (m) | -5.77% | 0.39× |
| 2026-03-31 | $3.80M | (m) | $5.66M | $1.86M | (m) | $193.33M | (m) | $-19.94M | (m) | (m) | 1.96% | -0.28× |
| 2025-12-31 | $6.41M | (m) | $8.28M | $1.87M | (m) | $194.06M | (m) | $14.35M | (m) | (m) | 3.30% | 0.58× |
| 2025-09-30 | $10.69M | (m) | $12.63M | $1.94M | (m) | $246.48M | (m) | $-10.55M | (m) | (m) | 4.34% | -1.20× |
| 2025-06-30 | $17.89M | (m) | $19.48M | $1.59M | (m) | $245.56M | (m) | $-5.93M | (m) | (m) | 7.28% | -3.29× |
| 2025-03-31 | $13.94M | (m) | $15.38M | $1.44M | (m) | $234.01M | (m) | $-10.73M | (m) | (m) | 5.96% | -1.43× |
| 2024-12-31 | $16.02M | (m) | $17.51M | $1.49M | (m) | $212.45M | (m) | $-18.88M | (m) | (m) | 7.54% | -0.93× |
| 2024-09-30 | $20.28M | (m) | $21.66M | $1.37M | (m) | $193.06M | (m) | $-22.51M | (m) | (m) | 10.51% | -0.96× |
| 2024-06-30 | $15.57M | (m) | $16.53M | $957.24K | (m) | $178.28M | (m) | $-23.50M | (m) | (m) | 8.74% | -0.70× |
| 2024-03-31 | $16.29M | (m) | $16.64M | $345.75K | (m) | $163.56M | (m) | $-23.36M | (m) | (m) | 9.96% | -0.71× |
| 2023-12-31 | $8.62M | (m) | $8.82M | $203.81K | (m) | $152.55M | (m) | $-20.60M | (m) | (m) | 5.65% | -0.43× |
| 2023-09-30 | $1.06M | (m) | $1.14M | $82.24K | (m) | $135.81M | (m) | $-28.80M | (m) | (m) | 0.78% | -0.04× |
| 2023-06-30 | $-2.79M | (m) | $-2.71M | $73.52K | (m) | $128.61M | (m) | $-29.96M | (m) | (m) | -2.17% | 0.09× |
| 2023-03-31 | $-17.59M | (m) | $-17.46M | $133.14K | (m) | $123.12M | (m) | $-36.24M | (m) | (m) | -14.29% | 0.48× |
| 2022-12-31 | $-23.30M | (m) | $-22.94M | $366.63K | (m) | $119.03M | (m) | $-45.54M | (m) | (m) | -19.58% | 0.50× |
| 2022-09-30 | $-27.35M | (m) | $-26.79M | $556.14K | (m) | $118.33M | (m) | $-51.71M | (m) | (m) | -23.11% | 0.52× |
| 2022-06-30 | $-32.02M | (m) | $-31.44M | $586.58K | (m) | $111.87M | (m) | $-58.78M | (m) | (m) | -28.63% | 0.53× |
| 2022-03-31 | (m) | (m) | $-32.07M | (m) | (m) | $103.72M | (m) | $-62.59M | (m) | (m) | (m) | 0.51× |
| 2021-12-31 | $-33.33M | (m) | $-33.09M | $247.37K | (m) | $92.88M | (m) | $-60.90M | (m) | (m) | -35.89% | 0.54× |
| 2021-09-30 | (m) | (m) | $-33.80M | (m) | (m) | $78.35M | (m) | $-75.04M | (m) | (m) | (m) | 0.45× |
| 2021-06-30 | (m) | (m) | $-30.87M | (m) | (m) | $64.41M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | $-21.90M | (m) | (m) | $51.19M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | $-12.13M | (m) | (m) | $37.29M | (m) | $-58.65M | (m) | (m) | (m) | 0.21× |
| 2020-09-30 | (m) | (m) | $-5.44M | (m) | (m) | $15.96M | (m) | $-27.11M | (m) | (m) | (m) | 0.20× |
| 2020-06-30 | (m) | (m) | $-1.49M | (m) | (m) | $8.08M | (m) | $-7.43M | (m) | (m) | (m) | 0.20× |
| 2020-03-31 | (m) | (m) | $366.30K | (m) | (m) | $1.69M | (m) | $-4.87M | (m) | (m) | (m) | -0.08× |
| 2019-12-31 | (m) | (m) | $251.41K | (m) | (m) | $83.55K | (m) | $-3.14M | (m) | (m) | (m) | -0.08× |
| 2019-09-30 | (m) | (m) | $-323.82K | (m) | (m) | $10.71M | (m) | $-3.19M | (m) | (m) | (m) | 0.10× |
| 2019-06-30 | (m) | (m) | $-26.69K | (m) | (m) | $10.08M | (m) | $-2.70M | (m) | (m) | (m) | 0.01× |
| 2019-03-31 | (m) | (m) | $-424.98K | (m) | (m) | $9.42M | (m) | $-2.53M | (m) | (m) | (m) | 0.17× |
| 2018-12-31 | (m) | (m) | $-905.52K | (m) | (m) | $8.32M | (m) | $-1.24M | (m) | (m) | (m) | 0.73× |
| 2018-09-30 | (m) | (m) | $-990.73K | (m) | (m) | (m) | (m) | $-748.31K | (m) | (m) | (m) | 1.32× |
| 2018-06-30 | (m) | (m) | $-532.82K | (m) | (m) | (m) | (m) | $-878.40K | (m) | (m) | (m) | 0.61× |
| 2018-03-31 | (m) | (m) | $-278.03K | (m) | (m) | (m) | (m) | $466.12K | (m) | (m) | (m) | -0.60× |
| 2017-12-31 | (m) | (m) | $-817.22K | (m) | (m) | (m) | (m) | $-1.21M | (m) | (m) | (m) | 0.68× |
| 2017-09-30 | (m) | (m) | $-611.90K | (m) | (m) | (m) | (m) | $-1.61M | (m) | (m) | (m) | 0.38× |
| 2017-06-30 | (m) | (m) | $-843.82K | (m) | (m) | (m) | (m) | $-1.15M | (m) | (m) | (m) | 0.73× |
| 2017-03-31 | (m) | (m) | $-759.01K | (m) | (m) | (m) | (m) | $-2.09M | (m) | (m) | (m) | 0.36× |
| 2016-12-31 | (m) | (m) | $-407.91K | (m) | (m) | (m) | (m) | $-1.11M | (m) | (m) | (m) | 0.37× |
| 2016-09-30 | (m) | (m) | $-326.51K | (m) | (m) | $4.63M | (m) | $-539.42K | (m) | (m) | (m) | 0.61× |
| 2016-06-30 | (m) | (m) | $-315.35K | (m) | (m) | $3.52M | (m) | $-304.65K | (m) | (m) | (m) | 1.04× |
| 2016-03-31 | (m) | (m) | $-347.09K | (m) | (m) | $2.57M | (m) | $-125.71K | (m) | (m) | (m) | 2.76× |
| 2015-12-31 | (m) | (m) | $-295.12K | (m) | (m) | $1.22M | (m) | $-61.99K | (m) | (m) | (m) | 4.76× |
| 2015-09-30 | (m) | (m) | $-54.82K | (m) | (m) | $1.01M | (m) | $-155.38K | (m) | (m) | (m) | 0.35× |
| 2015-06-30 | (m) | (m) | $-46.09K | (m) | (m) | $890.75K | (m) | $-267.40K | (m) | (m) | (m) | 0.17× |
| 2015-03-31 | (m) | (m) | $-30.10K | (m) | (m) | $810.01K | (m) | $-317.88K | (m) | (m) | (m) | 0.09× |
| 2014-12-31 | (m) | (m) | $33.44K | (m) | (m) | $714.16K | (m) | $-460.49K | (m) | (m) | (m) | -0.07× |
| 2014-09-30 | (m) | (m) | $-138.65K | (m) | (m) | $715.03K | (m) | $-387.90K | (m) | (m) | (m) | 0.36× |
| 2014-06-30 | (m) | (m) | $-198.11K | (m) | (m) | $644.24K | (m) | $-423.37K | (m) | (m) | (m) | 0.47× |
| 2014-03-31 | (m) | (m) | $-205.71K | (m) | (m) | $770.53K | (m) | $-367.71K | (m) | (m) | (m) | 0.56× |
| 2013-12-31 | (m) | (m) | $-259.07K | (m) | (m) | $808.36K | (m) | $-268.26K | (m) | (m) | (m) | 0.97× |
| 2013-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $-229.73K | (m) | (m) | $673.78K | (m) | $-445.65K | (m) | (m) | (m) | 0.52× |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Teladoc Health, Inc. (TDOC) | United States | $1.114B | -8.68 |